Oxurion Receives Transparency Notifications from Atlas
Regulated Information Leuven, BELGIUM, Boston, MA, US – August 23, 2023 – 8.00 PM CET Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company...
Stay updated with breaking news from Tom Graney. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Regulated Information Leuven, BELGIUM, Boston, MA, US – August 23, 2023 – 8.00 PM CET Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company...
Regulated Information Leuven, BELGIUM, Boston, MA, US – August 21, 2023 – 7.00 PM CET Oxurion NV , a biopharmaceutical company developing next generation standard of care ophthalmic therapies,...
Regulated Information Leuven, BELGIUM, Boston, MA, US – August 7, 2023 – 7.00 PM CET Oxurion NV a biopharmaceutical company developing next generation standard of care ophthalmic...
Regulated Information Leuven, BELGIUM, Boston, MA, US – July 5, 2023 – 7.00 PM CET Oxurion NV a biopharmaceutical company developing next generation standard of care ophthalmic...
AC Immune Holds Annual General Meeting of Shareholders Shareholders approved all resolutions as proposed by the Board of Directors Lausanne, Switzerland, June 23, 2023 – AC Immune SA (NASDAQ: ACIU), a clinical-stage biopharmaceutical company pion...